ABSTRACT
INTRODUCTION
Wolfram syndrome an autosomal recessive disorder (1, 2) , is characterized by non-inflammatory atrophic changes in the brain and in pancreatic islets resulting in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD). Genetic analysis has demonstrated mutations in the wolfram gene (WFS1) that encodes a 100-kDa tetrameric protein (wolframin) possessing 9-10 predicted transmembrane segments (3) are clearly associated with DIDMOAD syndrome (1) . This progressive, neurodegenerative disorder presents diabetes mellitus and optic atrophy in the first decade and cranial diabetes insipidus and sensorineural deafness in second decade. Sometimes the four cardinal features of WFS will be accompanied by anomalies of urinary tract and endocrine glands.
CASE REPORT
A 25 year old female postgraduate engineering student presented to the emergency department with alleged consumption of 30 tablets of Levocetrizine. She was a known diabetic since age of 5 years and was born of consanguineous marriage. Her parents were first degree cousins. Her only 15 year old brother was also diabetic since age of 6 years. Physical examination of the female revealed a conscious, well built and nourished individual. Neurological, cardio respiratory and abdominal examination were essentially normal at the time of admission. Preliminary investigations including electrolytes were also normal. On the 2 nd day of admission she went into coma. Investigations revealed polyuria (800ml/ hr) and hypernatremia (189meq/dl). Urinary sodium and osmolality were 75mEq/L and 510mEq/L respectively. However the blood sugar level was normal and urinary ketones were negative.
MRI scanning showed central pontine myelinolysis, bilateral optic atrophy, brain stem atrophy with prominent prepontine cistern and loss of normal hypersensitivity of posterior pituitary (figure I). Mild dilatation of the ventricles was detected. On desmopresin, her level of conciousness and sensorium improved and serum sodium and urine output became normal. During follow up visits pure tone audiometry showed loss of auditory acuity in both the ears. Ophthalmologic evaluation showed decrease in field of vision, visual acuity and evidence of optic atrophy with normal retina.
The brother was asymptomatic except for the diabetes mellitus and insipidus. His MRI brain showed loss of normal hyperintensity of posterior pituitary (data not included).
DISCUSSION
The incidence of WFS is reported to be greater in consanguineous parents, but the possibility that same clinical form may also appear in relatives of heterozygote subjects cannot be excluded. Table 1 compares the most common period of clinical manifestations in WFS (4) with the above described female patient. Diabetes mellitus and optic atrophy were manifested in 1 st decade and diabetes insipidus was manifested in 2 nd decade. Hypoacusis was present at the age of 25 years. However there was no renal dysfunction probably due to early age of presentation. Though associated neurological features are later manifestations of the syndrome our patient was admitted with alleged suicidal consumption at the age of 25 years.
The protein wolframin, 890 aminoacid glycoprotein is coded by WFS1 or wolframin gene and is localized to the endoplasmic reticulum in rat brain hippocampus and rat pancreatic islet E-cells (5) and studies (6) have demonstrated that the wolframin protein induced a large cation-selective ion channel that was blocked by Mg 2+ or Ca 2+ . Expression of wolframin increased cytosolic calcium levels in oocytes. Wolframin thus appears to be important in the regulation of intracellular Ca 2+ homeostasis. Disruption of this function may place cells at risk to suffer inappropriate death decisions, thus accounting for the progressive E-cell loss and neuronal degeneration associated with the disease. Among its many activities, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct 3-dimensional shape to function properly. The endoplasmic reticulum also helps to transport proteins, fats, and other materials to specific sites within the cell or to the cell surface. Based on its location in the endoplasmic reticulum, wolframin may play a role in protein folding or cellular transport. In the pancreas, wolframin may help to fold protein precursor of insulin (called proinsulin) into the mature hormone that controls blood glucose levels. WFS1 mutations results in highly unstable wolframin proteins which undergoes proteasomal degradation. Absence of wolframin aggregates in patient cells suggest wolfram syndrome is not protein aggregation disease rather it is due to loss-of-function by cellular depletion of wolframin (7). WFS-1 mutations leads to sensorinueral heraing loss (8) and mostly non-inactivating mutations are responsible for hearing impairment (9) . WFS1 gene is likely to play role in inner ear ion homeostasis as maintained by the canalicular reticulum (10) and it may help to maintain the correct cellular levels of calcium ions.
Not all patients with juvenile onset diabetes mellitus and optic atrophy have this syndrome. Other diagnoses include congenital rubella syndrome, hereditary optic neuropathy, Friedricks ataxia, Refsums syndrome, Lawrence -moon-beidl syndrome and Alstrom syndrome. Although these diseases share some major and minor neurological features of wolframs syndrome, it can be easily distinguished from others by clinical criteria. The recognition of clinical differences is important for correct therapy. The earlier the treatment better will be the outcome considering the high mortality index (about 65% at the age of 35 years) of patients with wolfram syndrome.
